A new treatment hailed as ‘groundbreaking’ has been rolled out across the country as part of the NHS' Long Term Plan, and could see as many as 2,000 patients benefit as a result. 5-ALA (5-AminoLevulinic Acid), dubbed ‘the pink drink’, uses fluorescent dye and ultraviolet light to make cancerous cells glow under UV light, enabling surgeons to more accurately identify the affected areas of the brain. This method will help to tackle some of the hardest to treat cases and...
READ MORE
|
Merck, a leading science and technology company, today announced that the CEO of its life science business, Udit Batra, was named “CEO of the Year” for 2016 by CPhI Pharma for his commitment to furthering life science innovation globally....
READ MORE
|
A California jury on Wednesday awarded $29 million to a woman who said that asbestos in Johnson & Johnson's talcum-powder-based products caused her cancer. The verdict, in California Superior Court in Oakland, marks the latest defeat for the healthcare conglomerate facing more than 13,000 talc-related lawsuits nationwide. J&J said it would appeal, citing "serious procedural and evidentiary errors" in the course of the trial, saying lawyers for the woman had fundamentally fa...
READ MORE
|
Sanofi’s Lantus is already facing off against generic competition from Eli Lilly and Boehringer’s Basaglar, but now Mylan is adding to the pressure by prevailing in a patent challenge at the U.S. Patent and Trademark Office. The PTO’s Patent Trial and Appeal Board invalidated two Lantus formulation patents, knocking down one barrier to market for Mylan and its partner Biocon as their generic awaits a decision at the FDA. The partners still face a patent fight with Sanofi in cou...
READ MORE
|
Performing a lab-quality test for many infectious diseases, particularly viral ones, is difficult in remote regions. Much lab equipment requires some kind of infrastructure, including clean rooms, trained staff, and money. Researchers at Purdue University have developed a device that can perform RNA amplification and testing in a tiny battery-powered package. The technology relies on strips of a paper-like material that can become saturated and can slowly move a liquid from its one end to anothe...
READ MORE
|
A leading pharma manufacturer in Europe approached Quantzig for assistance in evaluating the best vaccination strategy that is available in the manufacturing landscape. Quantzig assessed the budget impact of vaccinations using different vaccines. Since the incidence of vaccination in the market is increasing, the client wanted to quantify the health and budget impact of various vaccination strategies for pneumonia in adults and identify the most cost-effective method of treatment....
READ MORE
|